Head and neck cancer
Cetuximab can help treat colorectal cancer in patients whose cancer expressed epidermal growth factor receptor according to a randomized controlled trial. This trial did not include patients whose cancers did not express [epidermal growth factor receptor]].
Drug toxicity includes a acneiform papulopustular rash involving the face and trunk in about 10% of patients.Cite error: Closing
</ref> missing for
<ref> tag In patients with colorectal cancer, but not head and neck cancer, this rash is associated with improved survival.
- Anonymous (2015), Cetuximab (English). Medical Subject Headings. U.S. National Library of Medicine.
- Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al. (2008). "Platinum-based chemotherapy plus cetuximab in head and neck cancer.". N Engl J Med 359 (11): 1116-27. DOI:10.1056/NEJMoa0802656. PMID 18784101. Research Blogging.
- Jonker DJ, O'Callaghan CJ, Karapetis CS, et al (2007). "Cetuximab for the treatment of colorectal cancer". N. Engl. J. Med. 357 (20): 2040–8. DOI:10.1056/NEJMoa071834. PMID 18003960. Research Blogging.